357 Toripalimab plus chemoradiotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial

• Yue Wang,
• Hao Wang,
• Jun Jiang,
• Hui Miao,
• Xiaoting Xu,
• Jian Huan,
• Hongyu Zhu,
• Juying Zhou

Affiliations

Yue Wang

Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

Hao Wang

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, School of Medicine, Tongji University, Shanghai 200092, China

Jun Jiang

1 Department of Cardiothoracic Surgery, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China

Hui Miao

1Peking University, Beijing, China

Xiaoting Xu

1The First Affiliated Hospital of Soochow, Suzhou, China

Jian Huan

2The Affiliated Suzhou ScienceandTechnology, Suzhou, China

Hongyu Zhu

2The Affiliated Suzhou ScienceandTechnology, Suzhou, China

Juying Zhou

5The First Affiliated Hospital of Soochow University, Su Zhou, China